YAP and TAZ Take Center Stage in Cancer

Biochemistry

Volumn 54, Issue 43, 2015, Pages 6555-6566

  Zhang, Kun ^a   Qi, Hai Xia ^a   Hu, Zhi Mei ^a   Chang, Ya Nan ^a   Shi, Zhe Min ^a   Han, Xiao Hui ^a   Han, Ya Wei ^a   Zhang, Rui Xue ^b   Zhang, Zhen ^a   Chen, Ting ^a   Hong, Wei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; STEM CELLS; TRANSCRIPTION;

CANCER STEM CELLS; COACTIVATORS; CORE COMPONENTS; INTEGRAL PART; SELF RENEWAL; SIGNALING PATHWAYS; THERAPEUTIC TARGETS;

DISEASES;

ANDROGEN RECEPTOR; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; DICER; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN GP 130; MAMMALIAN TARGET OF RAPAMYCIN; MEVALONIC ACID; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SMAD PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TAZ; TRANSCRIPTION FACTOR YAP; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; PROTEIN SERINE THREONINE KINASE; RNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; DROSOPHILA; EXTRACELLULAR MATRIX; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; ANOXIA; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN PROCESSING; WNT SIGNALING PATHWAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANOXIA; GENE EXPRESSION REGULATION; HEDGEHOG PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MEVALONIC ACID; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANDROGEN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NOTCH; RNA, NEOPLASM; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

EID: 84946430139     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.5b01014     Document Type: Article

References (140)

1. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., and Jemal, A. (2015) Global cancer statistics, 2012 Ca-Cancer J. Clin. 65, 87-108 10.3322/caac.21262
2. Rosenbluh, J., Nijhawan, D., Cox, A. G., Li, X., Neal, J. T., Schafer, E. J., Zack, T. I., Wang, X., Tsherniak, A., Schinzel, A. C., Shao, D. D., Schumacher, S. E., Weir, B. A., Vazquez, F., Cowley, G. S., Root, D. E., Mesirov, J. P., Beroukhim, R., Kuo, C. J., Goessling, W., and Hahn, W. C. (2012) beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis Cell 151, 1457-1473 10.1016/j.cell.2012.11.026
3. Lei, C. J., Li, L., Gao, X., Zhang, J., Pan, Q. Y., Long, H. C., Chen, C. Z., Ren, D. F., and Zheng, G. (2015) Hsa-miR-132 inhibits proliferation of hepatic carcinoma cells by targeting YAP Cell Biochem Funct 33, 326-333 10.1002/cbf.3119
4. Liu, A. M., Poon, R. T., and Luk, J. M. (2010) MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties Biochem. Biophys. Res. Commun. 394, 623-627 10.1016/j.bbrc.2010.03.036
5. Tschaharganeh, D. F., Chen, X., Latzko, P., Malz, M., Gaida, M. M., Felix, K., Ladu, S., Singer, S., Pinna, F., Gretz, N., Sticht, C., Tomasi, M. L., Delogu, S., Evert, M., Fan, B., Ribback, S., Jiang, L., Brozzetti, S., Bergmann, F., Dombrowski, F., Schirmacher, P., Calvisi, D. F., and Breuhahn, K. (2013) Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma Gastroenterology 144, 1530-1542.e12 10.1053/j.gastro.2013.02.009
6. Wang, J., Ma, L., Weng, W., Qiao, Y., Zhang, Y., He, J., Wang, H., Xiao, W., Li, L., Chu, Q., Pan, Q., Yu, Y., and Sun, F. (2013) Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer Hepatology 58, 1011-1020 10.1002/hep.26420
7. Yu, W., Qiao, Y., Tang, X., Ma, L., Wang, Y., Zhang, X., Weng, W., Pan, Q., Yu, Y., Sun, F., and Wang, J. (2014) Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells Cell. Signalling 26, 2961-2968 10.1016/j.cellsig.2014.09.011
8. Dou, X., Wei, J., Sun, A., Shao, G., Childress, C., Yang, W., and Lin, Q. (2015) PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation Cancer Cell Int. 15, 27 10.1186/s12935-015-0178-0
9. Hiemer, S. E., Szymaniak, A. D., and Varelas, X. (2014) The transcriptional regulators TAZ. and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells J. Biol. Chem. 289, 13461-13474 10.1074/jbc.M113.529115
10. Rashidian, J., Le Scolan, E., Ji, X. D., Zhu, Q. W., Mulvihill, M. M., Nomura, D., and Luo, K. X. (2015) Ski regulates Hippo and TAZ signaling to suppress breast cancer progression Sci. Signaling 8, ra14 10.1126/scisignal.2005735
11. Xiang, L. S., Gilkes, D. M., Hu, H. X., Luo, W. B., Bullen, J. W., Liang, H. J., and Semenza, G. L. (2015) HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells Oncotarget 6, 11768 10.18632/oncotarget.4190
12. Cai, H. and Xu, Y. (2013) The role of LPA and YAP signaling in long- term migration of human ovarian cancer cells Cell Commun. Signaling 11, 31 10.1186/1478-811X-11-31
13. He, C., Lv, X., Hua, G., Lele, S. M., Remmenga, S., Dong, J., Davis, J. S., and Wang, C. (2015) YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression Oncogene 10.1038/onc.2015.52
14. You, B., Yang, Y. L., Xu, Z. D., Dai, Y. Y., Liu, S., Mao, J. H., Tetsu, O., Li, H., Jablons, D. M., and You, L. (2015) Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells Oncotarget 6, 4357 10.18632/oncotarget.2974
15. Nguyen, L. T., Tretiakova, M. S., Silvis, M. R., Lucas, J., Klezovitch, O., Coleman, I., Bolouri, H., Kutyavin, V. I., Morrissey, C., True, L. D., Nelson, P. S., and Vasioukhin, V. (2015) ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors Cancer Cell 27, 797-808 10.1016/j.ccell.2015.05.005
16. Zagurovskaya, M., Shareef, M. M., Das, A., Reeves, A., Gupta, S., Sudol, M., Bedford, M. T., Prichard, J., Mohiuddin, M., and Ahmed, M. M. (2009) EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells Oncogene 28, 1121-1131 10.1038/onc.2008.461
17. Zhang, L., Yang, S., Chen, X., Stauffer, S., Yu, F., Lele, S. M., Fu, K., Datta, K., Palermo, N., Chen, Y., and Dong, J. (2015) The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells Mol. Cell. Biol. 35, 1350-1362 10.1128/MCB.00102-15
18. Zhang, W., Nandakumar, N., Shi, Y., Manzano, M., Smith, A., Graham, G., Gupta, S., Vietsch, E. E., Laughlin, S. Z., Wadhwa, M., Chetram, M., Joshi, M., Wang, F., Kallakury, B., Toretsky, J., Wellstein, A., and Yi, C. (2014) Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma Sci. Signaling 7, ra42 10.1126/scisignal.2005049
19. Chan, L. H., Wang, W., Yeung, W., Deng, Y., Yuan, P., and Mak, K. K. (2014) Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression Oncogene 33, 4857-4866 10.1038/onc.2013.433
20. Artinian, N., Cloninger, C., Holmes, B., Benavides-Serrato, A., Bashir, T., and Gera, J. (2015) Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness J. Biol. Chem. 290, 19387-19401 10.1074/jbc.M115.656587
21. Yu, F. X., Luo, J., Mo, J. S., Liu, G., Kim, Y. C., Meng, Z., Zhao, L., Peyman, G., Ouyang, H., Jiang, W., Zhao, J., Chen, X., Zhang, L., Wang, C. Y., Bastian, B. C., Zhang, K., and Guan, K. L. (2014) Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP Cancer Cell 25, 822-830 10.1016/j.ccr.2014.04.017
22. Fernandez, L. A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D., and Kenney, A. M. (2009) YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation Genes Dev. 23, 2729-2741 10.1101/gad.1824509
23. Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., Hida, T., Tsujimura, T., Osada, H., and Sekido, Y. (2012) TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth J. Exp. Med. 209, 479-494 10.1084/jem.20111653
24. Justice, R. W., Zilian, O., Woods, D. F., Noll, M., and Bryant, P. J. (1995) The Drosophila tumor suppressor gene warts encodes a homolog o-f human myotonic dystrophy kinase and is required for the control of cell shape and proliferation Genes Dev. 9, 534-546 10.1101/gad.9.5.534
25. Chan, E. H., Nousiainen, M., Chalamalasetty, R. B., Schafer, A., Nigg, E. A., and Sillje, H. H. (2005) The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 Oncogene 24, 2076-2086 10.1038/sj.onc.1208445
26. Praskova, M., Xia, F., and Avruch, J. (2008) MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation Curr. Biol. 18, 311-321 10.1016/j.cub.2008.02.006
27. Callus, B. A., Verhagen, A. M., and Vaux, D. L. (2006) Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation FEBS J. 273, 4264-4276 10.1111/j.1742-4658.2006.05427.x
28. Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z. C., and Guan, K. L. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev. 21, 2747-2761 10.1101/gad.1602907
29. Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., and Pan, D. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals Cell 130, 1120-1133 10.1016/j.cell.2007.07.019
30. Kim, N. G., Koh, E., Chen, X., and Gumbiner, B. M. (2011) E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components Proc. Natl. Acad. Sci. U.S.A. 108, 11930-11935 10.1073/pnas.1103345108
31. Varelas, X., Samavarchi-Tehrani, P., Narimatsu, M., Weiss, A., Cockburn, K., Larsen, B. G., Rossant, J., and Wrana, J. L. (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway Dev. Cell 19, 831-844 10.1016/j.devcel.2010.11.012
32. Sun, Y., Yong, K. M., Villa-Diaz, L. G., Zhang, X., Chen, W., Philson, R., Weng, S., Xu, H., Krebsbach, P. H., and Fu, J. (2014) Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells Nat. Mater. 13, 599-604 10.1038/nmat3945
33. Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., Elvassore, N., and Piccolo, S. (2011) Role of YAP/TAZ in mechanotransduction Nature 474, 179-183 10.1038/nature10137
34. Yu, F. X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., Fu, X. D., Mills, G. B., and Guan, K. L. (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling Cell 150, 780-791 10.1016/j.cell.2012.06.037
35. Reddy, B. V. and Irvine, K. D. (2013) Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins Dev. Cell 24, 459-471 10.1016/j.devcel.2013.01.020
36. Taniguchi, K., Wu, L. W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F. X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., Sandborn, W. J., Hardiman, G., Raz, E., Maehara, Y., Yoshimura, A., Zucman-Rossi, J., Guan, K. L., and Karin, M. (2015) A gp130-Src-YAP module links inflammation to epithelial regeneration Nature 519, 57-62 10.1038/nature14228
37. Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A. H., Teruya-Feldstein, J., Gupta, S., Liang, H., Lin, H. K., Hung, M. C., and Ma, L. (2012) LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker Nat. Med. 18, 1511-1517 10.1038/nm.2940
38. Serrano, I., McDonald, P. C., Lock, F., Muller, W. J., and Dedhar, S. (2013) Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase Nat. Commun. 4, 2976 10.1038/ncomms3976
39. Nguyen, H. B., Babcock, J. T., Wells, C. D., and Quilliam, L. A. (2013) LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap Oncogene 32, 4100-4109 10.1038/onc.2012.431
40. Azzolin, L., Zanconato, F., Bresolin, S., Forcato, M., Basso, G., Bicciato, S., Cordenonsi, M., and Piccolo, S. (2012) Role of TAZ as mediator of Wnt signaling Cell 151, 1443-1456 10.1016/j.cell.2012.11.027
41. Cai, J., Maitra, A., Anders, R. A., Taketo, M. M., and Pan, D. (2015) beta-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis Genes Dev. 29, 1493-1506 10.1101/gad.264515.115
42. Konsavage, W. M., Jr., Kyler, S. L., Rennoll, S. A., Jin, G., and Yochum, G. S. (2012) Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells J. Biol. Chem. 287, 11730-11739 10.1074/jbc.M111.327767
43. Narimatsu, M., Samavarchi-Tehrani, P., Varelas, X., and Wrana, J. L. (2015) Distinct polarity cues direct Taz/Yap and TGFbeta receptor localization to differentially control TGFbeta-induced Smad signaling Dev. Cell 32, 652-656 10.1016/j.devcel.2015.02.019
44. Bendinelli, P., Maroni, P., Matteucci, E., Luzzati, A., Perrucchini, G., and Desiderio, M. A. (2013) Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer Eur. J. Cancer 49, 2608-2618 10.1016/j.ejca.2013.03.002
45. Ma, B., Chen, Y., Chen, L., Cheng, H., Mu, C., Li, J., Gao, R., Zhou, C., Cao, L., Liu, J., Zhu, Y., Chen, Q., and Wu, S. (2014) Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase Nat. Cell Biol. 17, 95-103 10.1038/ncb3073
46. Maroni, P., Matteucci, E., Drago, L., Banfi, G., Bendinelli, P., and Desiderio, M. A. (2015) Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1alpha stabilization/nuclear translocation in bone metastasis from breast carcinoma Exp. Cell Res. 330, 287-299 10.1016/j.yexcr.2014.10.004
47. Yan, L., Cai, Q., and Xu, Y. (2014) Hypoxic conditions differentially regulate TAZ and YAP in cancer cells Arch. Biochem. Biophys. 562, 31-36 10.1016/j.abb.2014.07.024
48. Sorrentino, G., Ruggeri, N., Specchia, V., Cordenonsi, M., Mano, M., Dupont, S., Manfrin, A., Ingallina, E., Sommaggio, R., Piazza, S., Rosato, A., Piccolo, S., and Del Sal, G. (2014) Metabolic control of YAP and TAZ by the mevalonate pathway Nat. Cell Biol. 16, 357-366 10.1038/ncb2936
49. Wang, Z., Wu, Y., Wang, H., Zhang, Y., Mei, L., Fang, X., Zhang, X., Zhang, F., Chen, H., Liu, Y., Jiang, Y., Sun, S., Zheng, Y., Li, N., and Huang, L. (2014) Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility Proc. Natl. Acad. Sci. U. S. A. 111, E89-98 10.1073/pnas.1319190110
50. Hong, J. H., Hwang, E. S., McManus, M. T., Amsterdam, A., Tian, Y., Kalmukova, R., Mueller, E., Benjamin, T., Spiegelman, B. M., Sharp, P. A., Hopkins, N., and Yaffe, M. B. (2005) TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation Science 309, 1074-1078 10.1126/science.1110955
51. Kim, M., Kim, T., Johnson, R. L., and Lim, D. S. (2015) Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ Cell Rep. 11, 270-282 10.1016/j.celrep.2015.03.015
52. Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S. J., Anders, R. A., Liu, J. O., and Pan, D. (2012) Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP Genes Dev. 26, 1300-1305 10.1101/gad.192856.112
53. Marti, P., Stein, C., Blumer, T., Abraham, Y., Dill, M. T., Pikiolek, M., Orsini, V., Jurisic, G., Megel, P., Makowska, Z., Agarinis, C., Tornillo, L., Bouwmeester, T., Ruffner, H., Bauer, A., Parker, C. N., Schmelzle, T., Terracciano, L. M., Heim, M. H., and Tchorz, J. S. (2015) YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors Hepatology 10.1002/hep.27992
54. Cui, C. B., Cooper, L. F., Yang, X., Karsenty, G., and Aukhil, I. (2003) Transcriptional Coactivation of Bone-Specific Transcription Factor Cbfa1 by TAZ Mol. Cell. Biol. 23, 1004-1013 10.1128/MCB.23.3.1004-1013.2003
55. Varelas, X., Sakuma, R., Samavarchi-Tehrani, P., Peerani, R., Rao, B. M., Dembowy, J., Yaffe, M. B., Zandstra, P. W., and Wrana, J. L. (2008) TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal Nat. Cell Biol. 10, 837-848 10.1038/ncb1748
56. Alarcon, C., Zaromytidou, A. I., Xi, Q., Gao, S., Yu, J., Fujisawa, S., Barlas, A., Miller, A. N., Manova-Todorova, K., Macias, M. J., Sapkota, G., Pan, D., and Massague, J. (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways Cell 139, 757-769 10.1016/j.cell.2009.09.035
57. Ferrigno, O., Lallemand, F., Verrecchia, F., L'Hoste, S., Camonis, J., Atfi, A., and Mauviel, A. (2002) Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-b/Smad signaling Oncogene 21, 4879 10.1038/sj.onc.1205623
58. Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., and Downward, J. (2003) Akt Phosphorylates the Yes-Associated Protein, YAP, to Induce Interaction with 14-3-3 and Attenuation of p73-Mediated Apoptosis Mol. Cell 11, 11-23 10.1016/S1097-2765(02)00776-1
59. Levy, D., Adamovich, Y., Reuven, N., and Shaul, Y. (2008) Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage Mol. Cell 29, 350-361 10.1016/j.molcel.2007.12.022
60. Tomlinson, V., Gudmundsdottir, K., Luong, P., Leung, K. Y., Knebel, A., and Basu, S. (2010) JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis Cell Death Dis. 1, e29 10.1038/cddis.2010.7
61. Chatterjee, A., Sen, T., Chang, X., and Sidransky, D. (2010) Yes-associated protein 1 regulates the stability of ΔNp63α Cell Cycle 9, 162-167 10.4161/cc.9.1.10321
62. Valencia-Sama, I., Zhao, Y., Lai, D., Janse van Rensburg, H. J., Hao, Y., and Yang, X. (2015) Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates DeltaNp63 Transcription through TEA Domain (TEAD) Transcription Factor J. Biol. Chem. 290, 16906-16917 10.1074/jbc.M115.642363
63. Xiang, L. S., Gilkes, D. M., Hu, H. X., Luo, W. B., Bullen, J. W., Samanta, D., Liang, H. J., and L, S. G. (2014) Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype Oncotarget 5, 12509-12527 10.18632/oncotarget.2997
64. Komuro, A., Nagai, M., Navin, N. E., and Sudol, M. (2003) WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus J. Biol. Chem. 278, 33334-33341 10.1074/jbc.M305597200
65. Wang, J., Park, J. S., Wei, Y., Rajurkar, M., Cotton, J. L., Fan, Q., Lewis, B. C., Ji, H., and Mao, J. (2013) TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPalpha function Mol. Cell 51, 211-225 10.1016/j.molcel.2013.05.013
66. Zhang, T., Zhang, J., You, X., Liu, Q., Du, Y., Gao, Y., Shan, C., Kong, G., Wang, Y., Yang, X., Ye, L., and Zhang, X. (2012) Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells Hepatology 56, 2051-2059 10.1002/hep.25899
67. Eisinger-Mathason, T. S., Mucaj, V., Biju, K. M., Nakazawa, M. S., Gohil, M., Cash, T. P., Yoon, S. S., Skuli, N., Park, K. M., Gerecht, S., and Simon, M. C. (2015) Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis Proc. Natl. Acad. Sci. U. S. A. 112, E3402-3411 10.1073/pnas.1420005112
68. Murakami, M., Nakagawa, M., Olson, E. N., and Nakagawa, O. (2005) A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome Proc. Natl. Acad. Sci. U. S. A. 102, 18034-18039 10.1073/pnas.0509109102
69. Beyer, T. A., Weiss, A., Khomchuk, Y., Huang, K., Ogunjimi, A. A., Varelas, X., and Wrana, J. L. (2013) Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells Cell Rep. 5, 1611-1624 10.1016/j.celrep.2013.11.021
70. Tariki, M., Dhanyamraju, P. K., Fendrich, V., Borggrefe, T., Feldmann, G., and Lauth, M. (2014) The Yes-associated protein controls the cell density regulation of Hedgehog signaling Oncogenesis 3, e112 10.1038/oncsis.2014.27
71. Kang, H. S., Beak, J. Y., Kim, Y. S., Herbert, R., and Jetten, A. M. (2009) Glis3 is associated with primary cilia and Wwtr1/TAZ and implicated in polycystic kidney disease Mol. Cell. Biol. 29, 2556-2569 10.1128/MCB.01620-08
72. Gao, Y., Shi, Q., Xu, S., Du, C., Liang, L., Wu, K., Wang, K., Wang, X., Chang, L. S., He, D., and Guo, P. (2014) Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells Int. J. Mol. Sci. 15, 15173-15187 10.3390/ijms150915173
73. Zhao, D., Zhi, X., Zhou, Z., and Chen, C. (2012) TAZ. antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis Carcinogenesis 33, 59-67 10.1093/carcin/bgr242
74. Zhi, X., Zhao, D., Zhou, Z., Liu, R., and Chen, C. (2012) YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor Am. J. Pathol. 180, 2452-2461 10.1016/j.ajpath.2012.02.025
75. Park, K. S., Whitsett, J. A., Di Palma, T., Hong, J. H., Yaffe, M. B., and Zannini, M. (2004) TAZ interacts with TTF-1 and regulates expression of surfactant protein-C J. Biol. Chem. 279, 17384-17390 10.1074/jbc.M312569200
76. Di Palma, T., D'Andrea, B., Liguori, G. L., Liguoro, A., de Cristofaro, T., Del Prete, D., Pappalardo, A., Mascia, A., and Zannini, M. (2009) TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation Exp. Cell Res. 315, 162-175 10.1016/j.yexcr.2008.10.016
77. Murakami, M., Tominaga, J., Makita, R., Uchijima, Y., Kurihara, Y., Nakagawa, O., Asano, T., and Kurihara, H. (2006) Transcriptional activity of Pax3 is co-activated by TAZ Biochem. Biophys. Res. Commun. 339, 533-539 10.1016/j.bbrc.2005.10.214
78. Jeong, H., Bae, S., An, S. Y., Byun, M. R., Hwang, J. H., Yaffe, M. B., Hong, J. H., and Hwang, E. S. (2010) TAZ as a novel enhancer of MyoD-mediated myogenic differentiation FASEB J. 24, 3310-3320 10.1096/fj.09-151324
79. Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., and Martin, J. F. (2011) Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size Science 332, 458-461 10.1126/science.1199010
80. Wang, J., Wang, H., Zhang, Y., Zhen, N., Zhang, L., Qiao, Y., Weng, W., Liu, X., Ma, L., Xiao, W., Yu, W., Chu, Q., Pan, Q., and Sun, F. (2014) Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer Cell. Signalling 26, 1048-1059 10.1016/j.cellsig.2014.01.022
81. Skibinski, A., Breindel, J. L., Prat, A., Galvan, P., Smith, E., Rolfs, A., Gupta, P. B., Labaer, J., and Kuperwasser, C. (2014) The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment Cell Rep. 6, 1059-1072 10.1016/j.celrep.2014.02.038
82. Qing, Y., Yin, F., Wang, W., Zheng, Y. G., Guo, P. F., Schozer, F., Deng, H., and Pan, D. J. (2014) The Hippo effector Yorkie activates transcription by interacting with a histone methyltransferase complex through Ncoa6 eLife 3, e02564 10.7554/eLife.02564
83. Mori, M., Triboulet, R., Mohseni, M., Schlegelmilch, K., Shrestha, K., Camargo, F. D., and Gregory, R. I. (2014) Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer Cell 156, 893-906 10.1016/j.cell.2013.12.043
84. Chaulk, S. G., Lattanzi, V. J., Hiemer, S. E., Fahlman, R. P., and Varelas, X. (2014) The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7 J. Biol. Chem. 289, 1886-1891 10.1074/jbc.C113.529362
85. Liu, C. Y., Zha, Z. Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C. J., Hong, W., Zhao, S., Xiong, Y., Lei, Q. Y., and Guan, K. L. (2010) The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase J. Biol. Chem. 285, 37159-37169 10.1074/jbc.M110.152942
86. Danovi, S. A., Rossi, M., Gudmundsdottir, K., Yuan, M., Melino, G., and Basu, S. (2008) Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis Cell Death Differ. 15, 217-219 10.1038/sj.cdd.4402226
87. Mo, J. S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D. S., and Guan, K. L. (2015) Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway Nat. Cell Biol. 17, 500-510 10.1038/ncb3111
88. Royer, C., Koch, S., Qin, X., Zak, J., Buti, L., Dudziec, E., Zhong, S., Ratnayaka, I., Srinivas, S., and Lu, X. (2014) ASPP2 links the apical lateral polarity complex to the regulation of YAP activity in epithelial cells PLoS One 9, e111384 10.1371/journal.pone.0111384
89. Wang, P., Bai, Y., Song, B., Wang, Y., Liu, D., Lai, Y., Bi, X., and Yuan, Z. (2011) PP1A-mediated dephosphorylation positively regulates YAP2 activity PLoS One 6, e24288 10.1371/journal.pone.0024288
90. Oudhoff, M. J., Freeman, S. A., Couzens, A. L., Antignano, F., Kuznetsova, E., Min, P. H., Northrop, J. P., Lehnertz, B., Barsyte-Lovejoy, D., Vedadi, M., Arrowsmith, C. H., Nishina, H., Gold, M. R., Rossi, F. M., Gingras, A. C., and Zaph, C. (2013) Control of the hippo pathway by Set7-dependent methylation of Yap Dev. Cell 26, 188-194 10.1016/j.devcel.2013.05.025
91. Adler, J. J., Heller, B. L., Bringman, L. R., Ranahan, W. P., Cocklin, R. R., Goebl, M. G., Oh, M., Lim, H. S., Ingham, R. J., and Wells, C. D. (2013) Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth J. Biol. Chem. 288, 15181-15193 10.1074/jbc.M112.446534
92. Hata, S., Hirayama, J., Kajiho, H., Nakagawa, K., Hata, Y., Katada, T., Furutani-Seiki, M., and Nishina, H. (2012) A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents J. Biol. Chem. 287, 22089-22098 10.1074/jbc.M111.334714
93. Tan, G. S., Cao, X. P., Dai, Q. S., Zhang, B., Huang, J. W., Xiong, S. Q., Zhang, Y. Y., Chen, W., Yang, J. Y., and Li, H. P. (2015) A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ Oncotarget 6, 8676 10.18632/oncotarget.3254
94. Yu, S. J., Hu, J. Y., Kuang, X. Y., Luo, J. M., Hou, Y. F., Di, G. H., Wu, J., Shen, Z. Z., Song, H. Y., and Shao, Z. M. (2013) MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer Clin. Cancer Res. 19, 1389-1399 10.1158/1078-0432.CCR-12-1959
95. Higashi, T., Hayashi, H., Ishimoto, T., Takeyama, H., Kaida, T., Arima, K., Taki, K., Sakamoto, K., Kuroki, H., Okabe, H., Nitta, H., Hashimoto, D., Chikamoto, A., Beppu, T., and Baba, H. (2015) miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells Br. J. Cancer 113, 252-258 10.1038/bjc.2015.170
96. Gao, Y., Wang, Y., Feng, J., Feng, G., Zheng, M., Yang, Z., Xiao, Z., Lu, Z., Ye, L., and Zhang, X. (2015) A hairpin within YAP mRNA 3′UTR functions in regulation at post-transcription level Biochem. Biophys. Res. Commun. 459, 306-312 10.1016/j.bbrc.2015.02.106
97. Akhtar Ali, M., Younis, S., Wallerman, O., Gupta, R., Andersson, L., and Sjoblom, T. (2015) Transcriptional modulator ZBED6 affects cell cycle and growth of human colorectal cancer cells Proc. Natl. Acad. Sci. U. S. A. 112, 7743-7748 10.1073/pnas.1509193112
98. Wu, H., Xiao, Y., Zhang, S., Ji, S., Wei, L., Fan, F., Geng, J., Tian, J., Sun, X., Qin, F., Jin, C., Lin, J., Yin, Z. Y., Zhang, T., Luo, L., Li, Y., Song, S., Lin, S. C., Deng, X., Camargo, F., Avruch, J., Chen, L., and Zhou, D. (2013) The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense Cell Rep. 3, 1663-1677 10.1016/j.celrep.2013.04.020
99. Ehsanian, R., Brown, M., Lu, H., Yang, X. P., Pattatheyil, A., Yan, B., Duggal, P., Chuang, R., Doondeea, J., Feller, S., Sudol, M., Chen, Z., and Van Waes, C. (2010) YAP dysregulation by phosphorylation or DeltaNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets Oncogene 29, 6160-6171 10.1038/onc.2010.339
100. Xu, B., Li, S. H., Zheng, R., Gao, S. B., Ding, L. H., Yin, Z. Y., Lin, X., Feng, Z. J., Zhang, S., and Wang, X. M. (2013) Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription Proc. Natl. Acad. Sci. U. S. A. 110, 17480 10.1073/pnas.1312022110
101. Hersey, P., Heinemann, A., Cullinane, C., Gallagher, S., Tiffen, J., Smithers, N., and McArthur, G. (2015) Combining BET and HDAC inhibitors to potentiate their effectiveness against melanoma and to suppress AKT and YAP signaling J. Clin. Oncol. 33, e13557
102. Hong, X., Nguyen, H. T., Chen, Q., Zhang, R., Hagman, Z., Voorhoeve, P. M., and Cohen, S. M. (2014) Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover EMBO J. 33, 2447-2457 10.15252/embj.201489385
103. Urtasun, R., Latasa, M. U., Demartis, M. I., Balzani, S., Goni, S., Garcia-Irigoyen, O., Elizalde, M., Azcona, M., Pascale, R. M., Feo, F., Bioulac-Sage, P., Balabaud, C., Muntane, J., Prieto, J., Berasain, C., and Avila, M. A. (2011) Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation Hepatology 54, 2149-2158 10.1002/hep.24587
104. Shao, D. D., Xue, W., Krall, E. B., Bhutkar, A., Piccioni, F., Wang, X., Schinzel, A. C., Sood, S., Rosenbluh, J., Kim, J. W., Zwang, Y., Roberts, T. M., Root, D. E., Jacks, T., and Hahn, W. C. (2014) KRAS and YAP1 converge to regulate EMT and tumor survival Cell 158, 171-184 10.1016/j.cell.2014.06.004
105. Li, Q., Li, S., Mana-Capelli, S., Roth Flach, R. J., Danai, L. V., Amcheslavsky, A., Nie, Y., Kaneko, S., Yao, X., Chen, X., Cotton, J. L., Mao, J., McCollum, D., Jiang, J., Czech, M. P., Xu, L., and Ip, Y. T. (2014) The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila Dev. Cell 31, 291-304 10.1016/j.devcel.2014.09.012
106. Xu, M. Z., Chan, S. W., Liu, A. M., Wong, K. F., Fan, S. T., Chen, J., Poon, R. T., Zender, L., Lowe, S. W., Hong, W., and Luk, J. M. (2011) AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma Oncogene 30, 1229 10.1038/onc.2010.504
107. Sun, G. P. and Irvine, K. D. (2013) Ajuba Family Proteins Link JNK to Hippo Signaling Sci. Signaling 6, ra81 10.1126/scisignal.2004324
108. Codelia, V. A., Sun, G., and Irvine, K. D. (2014) Regulation of YAP by mechanical strain through Jnk and Hippo signaling Curr. Biol. 24, 2012-2017 10.1016/j.cub.2014.07.034
109. Varelas, X., Miller, B. W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F. A., Sakuma, R., Pawson, T., Hunziker, W., McNeill, H., Wrana, J. L., and Attisano, L. (2010) The Hippo pathway regulates Wnt/beta-catenin signaling Dev. Cell 18, 579-591 10.1016/j.devcel.2010.03.007
110. Barry, E. R., Morikawa, T., Butler, B. L., Shrestha, K., de la Rosa, R., Yan, K. S., Fuchs, C. S., Magness, S. T., Smits, R., Ogino, S., Kuo, C. J., and Camargo, F. D. (2013) Restriction of intestinal stem cell expansion and the regenerative response by YAP Nature 493, 106-110 10.1038/nature11693
111. Imajo, M., Miyatake, K., Iimura, A., Miyamoto, A., and Nishida, E. (2012) A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling EMBO J. 31, 1109-1122 10.1038/emboj.2011.487
112. Tsutsumi, R., Masoudi, M., Takahashi, A., Fujii, Y., Hayashi, T., Kikuchi, I., Satou, Y., Taira, M., and Hatakeyama, M. (2013) YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function Dev. Cell 26, 658-665 10.1016/j.devcel.2013.08.013
113. Mahoney, J. E., Mori, M., Szymaniak, A. D., Varelas, X., and Cardoso, W. V. (2014) The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors Dev. Cell 30, 137-150 10.1016/j.devcel.2014.06.003
114. Grannas, K., Arngarden, L., Lonn, P., Mazurkiewicz, M., Blokzijl, A., Zieba, A., and Soderberg, O. (2015) Crosstalk between Hippo and TGFbeta: Subcellular Localization of YAP/TAZ/Smad Complexes J. Mol. Biol. 10.1016/j.jmb.2015.04.015
115. Nallet-Staub, F., Yin, X., Gilbert, C., Marsaud, V., Ben Mimoun, S., Javelaud, D., Leof, E. B., and Mauviel, A. (2015) Cell density sensing alters TGF-beta signaling in a cell-type-specific manner, independent from Hippo pathway activation Dev. Cell 32, 640-651 10.1016/j.devcel.2015.01.011
116. Li, X. J., Leem, S. H., Park, M. H., and Kim, S. M. (2013) Regulation of YAP through an Akt-dependent process by 3, 3′-diindolylmethane in human colon cancer cells Int. J. Oncol. 43, 1992-1998 10.3892/ijo.2013.2121
117. Fan, R., Kim, N. G., and Gumbiner, B. M. (2013) Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1 Proc. Natl. Acad. Sci. U. S. A. 110, 2569-2574 10.1073/pnas.1216462110
118. Xin, M., Kim, Y., Sutherland, L. B., Qi, X., McAnally, J., Schwartz, R. J., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2011) Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size Sci. Signaling 4, ra70 10.1126/scisignal.2002278
119. Tumaneng, K., Schlegelmilch, K., Russell, R. C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F. D., and Guan, K. L. (2012) YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29 Nat. Cell Biol. 14, 1322-1329 10.1038/ncb2615
120. Lin, Z., Zhou, P., von Gise, A., Gu, F., Ma, Q., Chen, J., Guo, H., van Gorp, P. R., Wang, D. Z., and Pu, W. T. (2015) Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival Circ. Res. 116, 35-45 10.1161/CIRCRESAHA.115.304457
121. Wennmann, D. O., Vollenbroker, B., Eckart, A. K., Bonse, J., Erdmann, F., Wolters, D. A., Schenk, L. K., Schulze, U., Kremerskothen, J., Weide, T., and Pavenstadt, H. (2014) The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes Cell Death Dis. 5, e1519 10.1038/cddis.2014.476
122. Mo, J. S., Yu, F. X., Gong, R., Brown, J. H., and Guan, K. L. (2012) Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs) Genes Dev. 26, 2138-2143 10.1101/gad.197582.112
123. Zhou, X., Wang, S., Wang, Z., Feng, X., Liu, P., Lv, X. B., Li, F., Yu, F. X., Sun, Y., Yuan, H., Zhu, H., Xiong, Y., Lei, Q. Y., and Guan, K. L. (2015) Estrogen regulates Hippo signaling via GPER in breast cancer J. Clin. Invest. 125, 2123-2135 10.1172/JCI79573
124. Chen, H. J., Wang, C. M., Wang, T. W., Liaw, G. J., Hsu, T. H., Lin, T. H., and Yu, J. Y. (2011) The Hippo pathway controls polar cell fate through Notch signaling during Drosophila oogenesis Dev. Biol. 357, 370-379 10.1016/j.ydbio.2011.07.003
125. Yu, J., Poulton, J., Huang, Y. C., and Deng, W. M. (2008) The hippo pathway promotes Notch signaling in regulation of cell differentiation, proliferation, and oocyte polarity PLoS One 3, e1761 10.1371/journal.pone.0001761
126. Reddy, B. V., Rauskolb, C., and Irvine, K. D. (2010) Influence of fat-hippo and notch signaling on the proliferation and differentiation of Drosophila optic neuroepithelia Development 137, 2397-2408 10.1242/dev.050013
127. Gutierrez-Avino, F. J., Ferres-Marco, D., and Dominguez, M. (2009) The position and function of the Notch-mediated eye growth organizer: the roles of JAK/STAT and four-jointed EMBO Rep. 10, 1051-1058 10.1038/embor.2009.140
128. Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., and Brummelkamp, T. R. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells Curr. Biol. 17, 2054-2060 10.1016/j.cub.2007.10.039
129. Yimlamai, D., Christodoulou, C., Galli, G. G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B. Z., and Camargo, F. D. (2014) Hippo pathway activity influences liver cell fate Cell 157, 1324-1338 10.1016/j.cell.2014.03.060
130. Li, Y., Hibbs, M. A., Gard, A. L., Shylo, N. A., and Yun, K. (2012) Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1 Stem Cells 30, 741-752 10.1002/stem.1030
131. Lin, Y. T., Ding, J. Y., Li, M. Y., Yeh, T. S., Wang, T. W., and Yu, J. Y. (2012) YAP regulates neuronal differentiation through Sonic hedgehog signaling pathway Exp. Cell Res. 318, 1877-1888 10.1016/j.yexcr.2012.05.005
132. Mi, W., Lin, Q., Childress, C., Sudol, M., Robishaw, J., Berlot, C. H., Shabahang, M., and Yang, W. (2015) Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration Oncogene 34, 3095-3106 10.1038/onc.2014.251
133. Cinar, B., Collak, F. K., Lopez, D., Akgul, S., Mukhopadhyay, N. K., Kilicarslan, M., Gioeli, D. G., and Freeman, M. R. (2011) MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling Cancer Res. 71, 4303-4313 10.1158/0008-5472.CAN-10-4532
134. Cottini, F., Hideshima, T., Xu, C., Sattler, M., Dori, M., Agnelli, L., ten Hacken, E., Bertilaccio, M. T., Antonini, E., Neri, A., Ponzoni, M., Marcatti, M., Richardson, P. G., Carrasco, R., Kimmelman, A. C., Wong, K. K., Caligaris-Cappio, F., Blandino, G., Kuehl, W. M., Anderson, K. C., and Tonon, G. (2014) Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers Nat. Med. 20, 599-606 10.1038/nm.3562
135. Staley, B. K. and Irvine, K. D. (2010) Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation Curr. Biol. 20, 1580-1587 10.1016/j.cub.2010.07.041
136. Ren, F., Wang, B., Yue, T., Yun, E. Y., Ip, Y. T., and Jiang, J. (2010) Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways Proc. Natl. Acad. Sci. U. S. A. 107, 21604-21609 10.1073/pnas.1012759107
137. Ciamporcero, E., Shen, H., Ramakrishnan, S., Yu Ku, S., Chintala, S., Shen, L., Adelaiye, R., Miles, K. M., Ullio, C., Pizzimenti, S., Daga, M., Azabdaftari, G., Attwood, K., Johnson, C., Zhang, J., Barrera, G., and Pili, R. (2015) YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage Oncogene 10.1038/onc.2015.219
138. Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., Wang, X., Guo, T., Li, P., Zhao, Y., Ji, H., Zhang, L., and Zhou, Z. (2014) A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer Cancer Cell 25, 166-180 10.1016/j.ccr.2014.01.010
139. Oku, Y., Nishiya, N., Shito, T., Yamamoto, R., Yamamoto, Y., Oyama, C., and Uehara, Y. (2015) Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers FEBS Open Bio 5, 542-549 10.1016/j.fob.2015.06.007
140. Lin, L., Sabnis, A. J., Chan, E., Olivas, V., Cade, L., Pazarentzos, E., Asthana, S., Neel, D., Yan, J. J., Lu, X., Pham, L., Wang, M. M., Karachaliou, N., Cao, M. G., Manzano, J. L., Ramirez, J. L., Torres, J. M., Buttitta, F., Rudin, C. M., Collisson, E. A., Algazi, A., Robinson, E., Osman, I., Munoz-Couselo, E., Cortes, J., Frederick, D. T., Cooper, Z. A., McMahon, M., Marchetti, A., Rosell, R., Flaherty, K. T., Wargo, J. A., and Bivona, T. G. (2015) The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Nat. Genet. 47, 250-256 10.1038/ng.3218